CMHS | JCSMR | ANU | Search ANU
The Australian National University
The John Curtin School of Medical Research
ANU COLLEGE OF MEDICINE AND HEALTH SCIENCES

Viral Immunology and Molecular Virology Group

Dr Matthias Regner, PhD
Research Fellow

Molecular Immunology and Virology
Division of Immunology and Genetics
The John Curtin School of Medical Research
The Australian National Unversity
Building 54, Mills Road
Acton ACT 0200
T: +61 2 6125 3084
E: Matthias.Regner@anu.edu.au


Biosketch:

Matthias grew up in Germany and studied chemistry in Germany and Denmark. His interest in immunology began during his Diplom-thesis on a topic in cancer immunology. His PhD research at JCSMR focused on the immunodominance, cross-reactivities and effector functions of the cytotoxic T cell response against viral infection, with an emphasis on Flavivirus infection.
After completion of his PhD he returned to Europe to investigate cytotoxic T cells and dendritic cells in the neonatal immune system, at the WHO Center for Vaccinology and Neonatal Immunology in Geneva, Switzerland.
He returned to JCSMR in 2003 where he continues to research the immunobiology of cytolytic lymphocytes, i.e. cytotoxic T cells and NK cells, in combating viral infection. His current research interests also include cytokine responses of the innate immune system.

Opportunities for postgraduate research students:

We focus on the role of cytotoxic T cells and Natural killer cells in infection with poxviruses and encephalitic RNA viruses. The mechanisms used to recognize and destroy virus-infected cells are of particular interest. Potential projects for postgraduate research students would be in the areas of
* Lymphocyte homing to the central nervous system in viral encephalitis; interaction between virus-specific cytotoxic T cells and virus-infected brain cells.
* Innate and cytotoxic T cell responses during flavivirus infection.
* Mechanisms of recovery and pathology in the infection with poxviruses.
Please refer also to other projects in the group: http://jcsmr.anu.edu.au/org/dig/vi-mv/resopp.php
Feel free to contact group members with any questions or your own ideas regarding your potential research in the laboratory.

Recent publications:

2006
Alsharifi M, Regner M, Lobigs M, Müllbacher A (2006) Exhaustion of IFN-I results in increased susceptibility to a second viral infection. J Immunol (in press).

Müllbacher A, Lobigs M, Alsharifi M, Regner M (2006) Cytotoxic T-cell immunity as a target for influenza vaccines. The Lancet Infectious Diseases 6:255-256.

2005
Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A, Müllbacher A (2005) Type I interferons trigger systemic, partial, lymphocyte activation in response to viral infection. J Immunol 175:4635-4640

2004
Hu KF, Regner M, Siegrist CA, Lambert PH, Chen M, Lövgren Bengtsson K, Morein B (2004) The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. FEMS Immunol. Med. Mic. 43:269-276.

Müllbacher A, Regner M, Wang Y, Lee E, Lobigs M, Simon MM (2004) Can we really learn from model pathogens? Trends Immunol. 25:524-528.

Xu DM, Regner M, Smith D, Ruby J, Johnstone R, Müllbacher A (2004) The multidrug resistance gene mdr1a influences resistance to ectromelia virus infection by mechanisms other than conventional immunity. Immunol Cell Biol. 82:462-470.

Regner M, Martinez X, Belnoue E, Sun CM, Boisgerault F, Lambert PH, Leclerc C, Siegrist CA (2004) Partial activation of neonatal CD11c+ DC and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J. Immunol. 173:2669-2674.

Regner M, Culley F, Fontanaz P, Hu KF, Morein B, Lambert PH, Openshaw PJ, Siegrist CA (2004) Safety and efficacy of ISCOM-based antigen delivery systems for neonatal immunization against respiratory syncytial virus infection. Microbes and Infection 6/7:666-675.

Regner M, Müllbacher A (2004) Granzymes in cytolytic lymphocytes – to kill a killer? Immunol. Cell Biol. 82:161-169.

2003
Lobigs M, Müllbacher A, Regner M (2003) MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen. Immunol. Cell Biol 81:217-223.

Martinez X, Regner M, Kovarik J, Zareh S, Bozzotti P, Hauser C, Lambert PH, Leclerc C, Siegrist CA (2003) CD4-independent protective cytotoxic T cells induced in early life by a non-replicative antigen delivery system based on virus-like particles. Virology 305:428-435.

2001
Regner M, Lobigs M, Blanden RV, Müllbacher A (2001) Effector cytolytic function but not IFN-? production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand. J. Immunol. 54:366-374.

Regner M, Lambert PH (2001) Autoimmunity through Infection or Immunization? Nature Immunol. 2:185-188.

Regner M, Lobigs M, Blanden RV, Milburn P, Müllbacher A (2001) Antiviral cytotoxic T cells cross-reactively recognize disparate peptide determinants from related viruses but ignore more similar Self and Foreign determinants.
J. Immunol. 166 :3820-3828.

Regner M (2001) Cross-reactivity in T cell antigen recognition. Immunol. Cell Biol. 79:91-100.

Regner M, Müllbacher A, Blanden RV, Lobigs M (2001) Immunodominance of two peptide determinants in the cytolytic T cell response to flavivirus infection: Inverse correlation of peptide affinity for MHC class I and T cell precursor frequency. Viral Immunol. 14:135-49.